ShaileshBhargaw

For Observation Purpose

看多
NSE:THYROCARE   THYROCARE TECHNOL
Because of cutting cost of Co-Vi-d test from ₹950 ( Earlier Price )to ₹700(After Cutting Cost ) all Diagnostic share came down,
And If this go to ₹1,000 Today on Dec17 then it will reach up to ₹1,200 in next 7 session, otherwise wait for upcoming Support

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。